Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @ASCO
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @ASCO
-
Prikvačeni tweet
Breaking news
Our 2020 Clinical Cancer Advances report is out, detailing progress in #cancerresearch from the past year https://fal.cn/36mse pic.twitter.com/SrTLQz2kyy
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The
@WaysMeansCmte is holding a hearing on overcoming pharmaceutical barriers. We’re tuning in live @ 2 PM https://fal.cn/36obw#ASCOAdvocacyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Less than one week remains to submit #ASCO20 abstracts!
https://fal.cn/36oaQ https://twitter.com/DrRaulCordoba/status/1225125971843592192 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
The American Society of Clinical Oncology (
@ASCO) released a position statement, “Block Grants in Medicaid https://www.asco.org/practice-policy/policy-issues-statements/asco-in-action/medicaid-block-grants-threaten-beneficiary …#gyncsmHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Oncologist and
@MSHO1985 past president@JeromeSeid testified before the Michigan State Senate to support reforms to#PriorAuthorization and step therapy to improve care for patients w cancer https://fal.cn/36nWL#ASCOAdvocacypic.twitter.com/x4AwwBiFip
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
Excited to partake in this year’s
#ImmunoOnc20 symposium!#immunotherapy#oncologyhttps://twitter.com/asco/status/1225056572126191617 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
@ASCO Education Scholars Program Graduates reunion, great refresh on#MedEd#SurgEd#learningscience!#edutwitter@jvonroennmd@MDRoeland@AMalone2012@kamarrone@MariaBaggstrom@DrSimon_UroOnc@JuliaLClose@annieimmcl@MeredithGiulia1pic.twitter.com/RKtiZJCwOe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
At
#OCEProject2025 now,@ASCO's Caroline Schenkel discusses the#CancerLinq study@rschilsky presented at#ASCO19 which showed the Use of Broader Criteria for#ClinicalTrial Enrollment Would **Double** Number of Eligible Patients w#LungCancer.
https://www.asco.org/about-asco/press-center/news-releases/use-broader-criteria-clinical-trial-enrollment-would-double …pic.twitter.com/DQ6PoDcYSx
Prikaži ovu nitHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Today
@BlasePolite testifies before the Illinois State Senate supporting#clinicaltrial coverage for pts w#Medicaid. Take action w him by using our ACT Network to contact your representatives
https://fal.cn/36nQs #ASCOAdvocacyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
Proud to have been a part of this incredible collaborative
@ASCO effort led by@DrMarkham and others. So much incredible progress made in the past year and so much more yet to come.#bcsm#CancerDay2020@WinshipAtEmoryhttps://twitter.com/ASCO/status/1224675229701746688 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
.
@ASCO Guideline: Germline Testing Recommended for All Women Diagnosed With Epithelial Ovarian Cancerhttps://www.cancertherapyadvisor.com/home/cancer-topics/gynecologic-cancer/ovarian-cancer-asco-guideline-germline-testing-recommendation-all-women/ …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re watching a
@EnergyCommerce Cmt hearing on “#Vaping in America: E-Cigarette Manufacturers' Impact on Public Health,” where the top#ecig makers are expected to testify. Tune in @ 10:30 AM https://fal.cn/36nNB#ASCOAdvocacyHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
TODAY is the last day for advance registration rates for the Multidisciplinary Head and Neck Cancers Symposium! Join us for this practical and interactive meeting for the entire head and neck cancer care community! http://ow.ly/gHIC50yeg2B
#HNCS20@sitcancer@ASCO@AHNSinfopic.twitter.com/33sbyJLYhn
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
#BreakingNews -@ASCO’s 2020 Clinical Cancer Advances report spotlights refinement in#surgicaloncology as the Advance of the Year. Read about how#SurgOnc has changed & what that means for patients. http://bit.ly/ASCOCCA2020#WorldCancerDay
#NCPM#cancerresearchHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
Our Fellowship graduate, Dr. Omid Etemadi, helped bring integrative cancer care to his community in the Philippines and has been Executive Director of CancerCare Cancer Supportive Care Philippines for the last 8 years!
@ASCO http://bit.ly/2RWRKBJ#oncology#worldcancerday
pic.twitter.com/BTPqwTwPsQ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
Among others, great to see these
@ASCO highlighted areas for research priorities: - Reduce Adverse Consequences of Cancer Treatment - Reduce Obesity’s Impact on Cancer Incidence and Outcomes - Optimize Care for Older Adults With Cancer#survonchttps://twitter.com/asco/status/1224675229701746688 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
Can’t wait to look through this! Thanks
@ASCO@ASCOPreshttps://twitter.com/asco/status/1224675229701746688 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
"What will each one of us around the globe do to keep pushing for changes and evidence that will help us reduce the incidence and burden of cancer?"
@CliffordHudishttps://twitter.com/ASCO/status/1224780919141216256 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
Following significant progress made in the development of novel systemic therapies for patients with
#cancer, the role of surgery in oncology continues to evolve, causing@ASCO to select the refinement of surgical treatment of cancer as Advance of the Yearhttp://ow.ly/XAQV50ydGNUHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
ASCO proslijedio/la je Tweet
Honored to be an
@ASCO featured voice again this year for#ImmunoOnc20! I’m looking forward to a great meeting and to sharing updates on new breakthroughs in cancer#immunotherapy.@OncoAlertHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
The Clinical Immuno-Oncology Symposium starts tomorrow!
Follow our Featured Voices and join the discussion using #ImmunoOnc20@DrBetofMDPhD@gulleyj1@DrKarineTawagi cc@sitcancerpic.twitter.com/jADEwfTBug
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.
Just submitted the abstracts of my research team to
If you didn't, you are still on time until Tuesday, February 11, 2020.
Don't miss the chance!!